| 1 | EXAS | Exact Sciences Corporation | 4.95% |
| 2 | VCYT | Veracyte, Inc. | 4.05% |
| 3 | BRKR | Bruker Corporation | 4.00% |
| 4 | NTRA | Natera, Inc. | 3.99% |
| 5 | REGN | Regeneron Pharmaceuticals, Inc. | 3.98% |
| 6 | ILMN | Illumina, Inc. | 3.95% |
| 7 | INCY | Incyte Corporation | 3.60% |
| 8 | WAT | Waters Corporation | 3.56% |
| 9 | BIIB | Biogen Inc. | 3.55% |
| 10 | ACAD | ACADIA Pharmaceuticals Inc. | 3.47% |
| 11 | KRYS | Krystal Biotech, Inc. | 3.42% |
| 12 | RGEN | Repligen Corporation | 3.38% |
| 13 | MTD | Mettler-Toledo International Inc. | 3.38% |
| 14 | AMGN | Amgen Inc. | 3.36% |
| 15 | ARGX | argenx SE | 3.29% |
| 16 | HALO | Halozyme Therapeutics, Inc. | 3.25% |
| 17 | EXEL | Exelixis, Inc. | 3.23% |
| 18 | UTHR | United Therapeutics Corporation | 3.15% |
| 19 | CORT | Corcept Therapeutics Incorporated | 3.10% |
| 20 | GILD | Gilead Sciences, Inc. | 3.10% |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 3.07% |
| 22 | VRTX | Vertex Pharmaceuticals Incorporated | 3.01% |
| 23 | NBIX | Neurocrine Biosciences, Inc. | 3.00% |
| 24 | ONC | BeOne Medicines AG | 2.99% |
| 25 | GMAB | Genmab A/S | 2.82% |
| View FBT holdings |
